The BVA-100 (Blood Volume Analyzer) is a revolutionary instrument, developed by DAXOR Corporation and cleared by the FDA, to precisely measure blood volume in the human body.

Read More

Key Features

  • Superior  blood volume measurement
  • Results in under 1 hour
  • Clinically proven — used in leading hospitals

Latest News

Daxor Receives Two Patents, One for Measurement of Total Body Albumin and a Second Patent for Improved Accuracy of Blood Volume Measurement

Daxor has received approval from the US Patent Office for a Total Body Albumin Analyzer, US Patent # 9,002,656. The patent for the total body albumin analyzer is the first one issued for an instrument to measure the total albumin within the human body.  Albumin is the major carrier molecule in the human body for […]

Read More

Daxor Corporation Announces Filing of Form N-CSR for June 30, 2015

NEW YORK, NY–(Marketwired – Aug 28, 2015) – Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, will be filing a Form N-CSR on Monday, August 31st, disclosing its schedule of portfolio holdings as of June 30, 2015. Copies of the form will be mailed to the Company’s shareholders and will be available […]

Read More

Daxor Announces an Update on its Stock Buyback Program and Changes in Marketing

Daxor Corporation, (NYSE MKT: DXR) an investment company with medical instrumentation and biotechnology operations announced an update on its stock buyback program today. The Board of Directors of Daxor Corporation has given management the authority to repurchase up to 250,000 shares of its common stock in 2015. From January 1, 2015 through August 12, 2015, […]

Read More